“Many of our young patients have complex medical problems in addition to sleep problems. Therefore, we are excited to have recently welcomed three new faculty members, each bringing a unique med…
Tag: Pulmonary
Healthcare to Research: The Many Ways Genetic Counselors Help Patients and Families
Genetic counselors are experts in genetics and how it impacts our health and development. Learn more about who they are, what they do and how they may help you and your family….
Penn Study Finds Better Survival Rates for Recipients of Lungs From Hospital-based Donor Care Units Compared to Independent Donor Care Units
A new study by Penn researchers examined, for the first time, the differences in lung transplant graft outcomes from organs recovered from the two types of deceased organ donor care facilities operating in the United States.
Breakthrough Research Identifies Predictors of Venous Thromboembolism after Pulmonary Resection for Lung Cancer
In patients who undergo pulmonary resection for lung cancer, a major potential postoperative complication is venous thromboembolism (VTE)—a condition that develops when a blood clot forms in a vein—which can lead to part of the clot breaking off and lodging in the lung, resulting in a pulmonary embolism (PE).
Share Your Research with the Respiratory Disease Community at ATS 2024 in San Diego
The American Thoracic Society is accepting scientific abstracts and case report submissions for presentation at the ATS 2024 International Conference in San Diego, May 17-22. Submissions on all aspects of respiratory disease, critical care medicine and sleep medicine will be considered and are due no later than Wednesday, Nov. 1, 2023, at 5 p.m. ET.
Save the Date! Washington, DC to Host ATS 2023
It has been six years since the ATS International Conference was last held in Washington, DC, and the world has changed dramatically. We are excited to welcome you back to the nation’s capital for ATS 2023, when we will engage leaders, as well as emerging scientists and clinicians, in passionate discussions of medical breakthroughs and clinical innovation to meet the needs of patients worldwide.
Dr. George Alba Announced as Latest Harold Amos Scholar in Pulmonary and Critical Care Medicine
George Alba, MD, of Massachusetts General Hospital/Harvard has been named the inaugural American Thoracic Society/American Lung Association/American College of Chest Physicians-Harold Amos Medical Faculty Development Program Scholar.
American Association of Cardiovascular and Pulmonary Rehabilitation Recertifies Hackensack Meridian JFK Johnson Rehabilitation Institute’s Pulmonary Rehabilitation Program
“We are pleased to receive this prestigious recertification from the American Association of Cardiovascular and Pulmonary Rehabilitation,” said Sara Cuccurullo, MD, chair, vice president, and medical director, JFK Johnson Rehabilitation Institute.
More Coronary Disease Among COPD Patients
Patients with chronic obstructive pulmonary disease (COPD) often have other comorbid disorders, a new study from Norway shows.
Computational Evaluation of Drug Delivery Reveals Room for Inhalers Improvement
Increased air pollution in recent years has exacerbated health risks for people who suffer from pulmonary diseases and these dynamics underscore the importance of increasing the efficacy of drug delivery devices that administer active pharmaceutical ingredients to treat respiratory illnesses. In Physics of Fluids, researchers describe developing a computational evaluation of drug delivery through both pressurized metered-dose inhalers and dry powder inhalers to determine how the process can be improved.
Mount Sinai’s Simulation Teaching and Research Center Earns Four Accreditations From Society for Simulation in Healthcare
Only center in the world with this combination of distinctions
University Hospitals First in Northeast Ohio to Use New Technology for Lung Cancer Diagnosis
A new innovation that holds promise to fight lung cancer is now in use at University Hospitals Cleveland Medical Center.
University of Miami Health System Sarcoidosis Program Recognized as Center of Excellence
With its multidisciplinary approach to patient care, research and education, the University of Miami Sarcoidosis Program has been recognized as one of world’s leading centers for this complex multisystem disorder by the World Association of Sarcoidosis and Other Granulomatous Diseases/Foundation of Sarcoidosis Research (WASOG-FSR).
UC Davis Health announces Post-COVID-19 Clinic for long-haul patients
UC Davis Health is one of only a handful of health systems in the U.S. to launch a Post-COVID-19 Clinic to care for long-haul COVID patients whose symptoms go on and on, sometimes for months, with no clear explanation or avenue for treatment.
UCLA pulmonary expert to speak on air quality and wildfires
Dr. Reza Ronaghi, a pulmonologist at the David Geffen School of Medicine at UCLA, explains how wildfires affect air quality and what precautions people can take to limit exposure to smoke and other fire-generated toxins in the air. How do you…
University of Miami Health System researchers publish overview of evidence that COVID-19’s impact affects much more than the lungs
Studies suggest COVID-19 patients may at first present with atypical neurologic, gastrointestinal, cardiac and musculoskeletal imaging findings, which are more likely to go undiagnosed, according to the paper “Clinical Characteristics and Multisystem Imaging Findings of COVID-19: An Overview for Orthopedic Surgeons,” published August 17 in HHS Journal: the musculoskeletal journal of Hospital for Special Surgery.
Dilated Blood Vessels in the Lung May Explain Low Oxygen Levels in Severe Cases of COVID-19
A new pilot study from the Icahn School of Medicine at Mount Sinai suggests that COVID-19 is causing significant dilation of the blood vessels of the lung, specifically the capillaries.
Study: Enzyme Could Prove Effective in Treating Tumors and Inflammatory Diseases in Lung
Findings from a research study, led by scientists at Henry Ford, suggest an enzyme could play an important role in the treatment of cancer and autoimmune diseases in the airway.
Mount Sinai Study Finds COVID-19 May Be Driven by Pulmonary Thrombi and Pulmonary Endothelial Dysfunction
A new study from the Icahn School of Medicine at Mount Sinai suggests that blood clots, especially in the lungs, may play a role in severe cases of COVID-19.
Joint Statement: A Call to Action for America to Fight COVID-19
The American Association of Critical-Care Nurses, with other healthcare organizations, has released a statement calling upon the government, private sector and all other Americans to “uphold their moral obligation by joining us in fighting the battle against coronavirus and the resulting COVID-19 disease.”
Rates of Pulmonary Complications Drastically Reduced with Newer Drug
Improved pulmonary outcomes in surgical patients who receive the drug sugammadex could be due to a more complete reversal of the effects of muscle relaxants used during surgery.
American Association of Critical-Care Nurses Creates Custom COVID-19 Online Course
The American Association of Critical-Care Nurses has created an online course that specifically addresses the most serious reported symptoms from COVID-19. The course is available to all nurses, at no charge, to provide vital resources during this challenging time.
Register to Cover the Latest Science at ATS 2020!
The American Thoracic Society will host the world’s leading scientists and clinicians in pulmonary, critical care, and sleep medicine at the ATS 2020 International Conference (ATS 2020).
Icahn School of Medicine at Mount Sinai Announces Recipients of Nation’s First Gender Equity Grants
Annual Distinguished Scholar Award Aims to Break Down Barriers to Equity in Medical Research
Following the lizard lung labyrinth
Mammals inhale oxygen-rich air and they exhale depleted air, exhibiting a so-called tidal flow pattern. In contrast, bird breath travels through part of the respiratory system, but in a one-way loop throughout most of the lung. Biologists have discovered that Savannah monitor lizards have lung structures that are hybrid system of bird and mammal lungs.
New Report Shows Dramatic Health Benefits Following Air Pollution Reduction
Dec. 6, 2019 – Reductions in air pollution yielded fast and dramatic impacts on health-outcomes, as well as decreases in all-cause morbidity, according to findings in “Health Benefits of Air Pollution Reduction,” new research published in the American Thoracic Society’s journal, Annals of the American Thoracic Society.
What You Need to Know About Vaping-Associated Lung Injury
Vaping-associated lung injury is a condition characterized by lung inflammation and damage that can lead to respiratory failure and death. Symptoms include shortness of breath, cough, and chest pain, as well as fatigue, fever, and weight loss. Many patients report gastrointestinal symptoms too.
Healthcare experts are urging people to avoid vaping because the exact cause of vaping-associated lung injury is unknown.
People who are using vaping products — especially young people, who have been most frequently affected by the condition — should closely monitor their health and seek immediate medical care if they develop symptoms.